News Sentiment

OSE sentiment intelligence

OSE Immunotherapeutics SA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 5 relevant articles
Exchange PAR France
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.32 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

68/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-11.0% over one week, -14.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing

Market Reaction

Price moving ahead of tone

54/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 68/100 classification
One-week reaction -11.0% Price reacting lower
Trend fit Trend inactive -14.6% over four weeks
Fair value -40.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 3
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 2
Idéal Investisseur 2
simplywall.st 1

Event Lens

What the news is about

Classified themes
Market update 3
Balance sheet 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5